Firstcall Research is bullish on GSK pharmaceutical and has recommended buy rating on the stock with a target of Rs 2450 in its April 18, 2011 research report.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!